Pharma wrap: No respite for Glenmark, USFDA’s warning letter on Baddi facility adds to woes

The warning letter comes at a time when the company has been struggling with high debt and lack of meaningful approvals for products that can shore-up declining US sales

from Moneycontrol Business News https://www.moneycontrol.com/news/business/pharma-wrap-no-respite-for-glenmark-usfda’s-warning-letterbaddi-facility-adds-to-woes_13047081.html